VBL Therapeutics is currently up over 50% or 6c to almost 20c per share in morning trading on Thursday. VBL Therapeutics and Notable Labs announced they have entered into a definitive merger agreement. The combined company will focus on the advancement of Notable’s proprietary Predictive Precision Medicines Platform and therapeutic pipeline focused on cancer patients with high unmet medical needs.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on VBLT:
- VBL Therapeutics and Notable Labs Announce Definitive Merger Agreement
- VBL Therapeutics, Notable Labs enter definitive merger agreement
- VBL Therapeutics to sell manufacturing facility, certain assets for $7.1M
- VBL Therapeutics Announces Agreement to Sell Manufacturing Facility and Certain Related Assets for $7.1 Million in Cash
